Vestal Point Capital, LP Ionis Pharmaceuticals Inc Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 595,000 shares of IONS stock, worth $18.9 Million. This represents 1.23% of its overall portfolio holdings.
Number of Shares
595,000Holding current value
$18.9 Million% of portfolio
1.23%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$524 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$451 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$365 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$328 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$276 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.52B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...